Mikhail Blagosklonny and his Research in Rapamycin to Ensure Better Quality Life for Humans

In the recent years, Rapamycin has got increased significance due to various researches revealed many health benefits. When it was isolated from a bacterium in Easter Island in the year 1972, physicians could not understand the complete utilization of the drug and started using as an anti-fungal agent. But, in the later years, researchers found that it has excellent antiproliferative and immunosuppressive properties that helped the drug for various medicinal applications. The studies on the benefits of Rapamycin has got amplified when Mikhail Blagosklonny, a leading anti-aging and cancer researcher, focused on the properties of the drug. He says that Rapamycin is one of the best medicines with numerous applications.

He says that the Immunosuppressant properties of Rapamycin are making it as an ideal choice to avert the body reaction to reject the implanted organ in the case of organ transplant. While other Immunosuppressant drugs are toxic in nature and affect kidneys, Rapamycin has a very low level of toxicity and creates negligible harm to kidneys. The drug is also an ideal choice for treating people who are struggling with hemolytic-uremic syndrome – a rare health condition of low platelet count, anemia, and kidney failure. Blagosklonny also says that the drug is extremely effective in Lymphangioleiomyomatosis – a rare lung disease that affects women during their pregnancy stage. Read more about Mikhail on Crunchbase.

Mikhail Blagosklonny found that the drug can also be used in coating the coronary stents as Rapamycin prevents any chances of re-stenosis, especially in the arteries. He further adds that when taken in right doses, it would improve the immune response of the humans, and that can ensure tumor regression. Anti-aging properties of Rapamycin is the most prominent area Blagosklonny researched extensively and found that it can produce highly-convincing results. The tests he conducted on mice proved that it improved the lifespan of mice and suppressed tuberculosis. Currently, Blagosklonny is working on further researches to bring more factors of longevity while using Rapamycin.

Blagosklonny is also a philanthropist and professor with enormous student base across the globe. He is a proponent of bringing medicines that can be affordable to people irrespective of their financial conditions. Majority of his researches are based on anti-aging and cancer treatment. His peers and students often consult with Mikhail Blagosklonny as an expert advisory on their research findings and assumptions. Researchers and physicians around the world watch for his studies and findings and consider him as an authority in healthcare research. View Mikhail’s profile on Google Scholar.

Mikhail Blagosklonny is deeply concerned about the struggles of cancer patients and looks for options that administer more effective treatments than current times. He thinks that while the treatment being effective, it should also be inexpensive to make it accessible to everyone in the society. Blagosklonny is working on a treatment procedure that can remove cancer cells from the human body without damaging any of the healthy cells. If he could achieve that, it would be a revolution in cancer treatment as it gives more efficient results along with better recovery compared to current procedures. Also, it will significantly reduce the struggles of cancer patients during the treatment regime.

Follow: https://www.linkedin.com/in/mikhail-blagosklonny-91abb531

Comments are closed.